In this commentary CLL experts examine shared and regionspecific perspectives on sequencing therapy after BTK inhibitor andor venetoclaxbased therapy exposure and discuss how emerging evidence is shaping clinical practice across the United States and Europe
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
97% of listed courses are free
292 of a sample of 300 are free · 543 courses listed here.
Collected from the provider’s public pages · source
Specialties served/covered
- Addiction Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Clinical Informatics
- Clinician Wellness & Burnout
- Communication & Shared Decision-Making
- Critical Care Medicine
- Dermatology
- Diagnostic Radiology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Evidence-Based Medicine & Research
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Pediatrics
- Geriatric Medicine
- Geriatric Psychiatry
- Head & Neck Surgery
- Health Equity & Inclusion
- Hematology
- Infectious Disease
- Laryngology
- Medical Genetics & Genomics
- Medical Leadership & Administration
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Neonatal-Perinatal Medicine
- Nephrology
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Obstetrics & Gynecology
- Otology & Neurotology
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Hematology-Oncology
- Pediatric Infectious Diseases
- Pediatric Otolaryngology
- Psychopharmacology
- Psychotic Disorders
- Pulmonary Disease
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Thoracic Surgery
- Transplant Hepatology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pain & Palliative
- Pathology & Lab
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- Credit · Up to 0.25 credits
- Commercial Support
-
ReleasedJun 30, 2026
-
Last day to claim creditDec 30, 2026 3 months left
-
HealthTree Foundation for Chronic Lymphocytic Leukemia +1 Rethinking the CLL Treatment Sequence: Guidance on Selecting and Sequencing Modern Therapies for Sustained Efficacy Across Lines of Therapy
-
Talem Health, LLC Navigating Resistance, Relapse, and Treatment Sequencing in Relapsed/Refractory CLL
-
Society of Hematologic Oncology +1 Relapsed/Refractory CLL/SLL Clinical Insights: Navigating Novel Therapy Integration and Sequencing Considerations – Mobile Microlearning
-
CLL Society +1 Optimizing Patient-Centered Care for Relapsed/Refractory CLL With the Latest Evidence and Guideline Updates: Precision Education With Real-world Insights
-
CLL Society +1 Beyond CIT: Uniting Patient Voices With the Latest Evidence on Novel Targeted Therapies for CLL/SLL
-
CLL Society +1 Interactive Case Challenge: Treating R/R CLL After Progression on Frontline Acalabrutinib Plus Venetoclax and Impaired Renal Function
